RPL12P38 and hepatocellular carcinoma: As shown in Figure 6b, C15orf38-AP3S2, SLC6A6, SNORA18 and RPL12P38 emerged as candidates as they were both upregulated in HCC cells with SFN treatment and DDX24 knockdown.